Q4 2025 Holdings
Filed 2026-02-13 | 66 holdings | $137.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $21.1M | 2,732,079 | 15.4% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $13.5M | 740,000 | 9.9% |
| Evolus Inc(EOLS) | COM | 30052C107 | $10.9M | 1,631,588 | 7.9% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $5.1M | 569,088 | 3.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $4.8M | 2,348,147 | 3.5% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $3.7M | 709,505 | 2.7% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $3.6M | 85,000 | 2.6% |
| Indivior PLC(INDV) | ORD | G4766E116 | $3.6M | 100,000 | 2.6% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $3.2M | 389,916 | 2.3% |
| Kazia Therapeutics LTD | SPONSORED ADS | 48669G303 | $3.2M | 460,359 | 2.3% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $3.1M | 115,000 | 2.2% |
| Verrica Pharmaceuticals Inc(VRCA) | COM SHS | 92511W207 | $2.9M | 353,669 | 2.1% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $2.8M | 339,902 | 2.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $2.8M | 2,352,032 | 2.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.7M | 100,000 | 2.0% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $2.6M | 50,000 | 1.9% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $2.6M | 113,631 | 1.9% |
| Alexandria Real Estate EQ in(ARE)Call | COM NEW | 015271109 | $2.4M | 50,000 | 1.8% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $2.4M | 593,573 | 1.7% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $2.3M | 100,000 | 1.7% |
| Aytu Biopharma Inc(AYTU) | COM | 054754858 | $2.1M | 813,704 | 1.5% |
| Nektar Therapeutics(NKTR)Call | COM NEW | 640268306 | $2.1M | 50,000 | 1.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $1.9M | 200,000 | 1.4% |
| Adicet BIO Inc(ACET) | COM NEW | 007002207 | $1.9M | 220,011 | 1.4% |
| Spruce Biosciences Inc(SPRB) | COM NEW | 85209E208 | $1.7M | 19,742 | 1.3% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $1.6M | 1,237,802 | 1.2% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $1.6M | 100,000 | 1.2% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $1.4M | 1,150,759 | 1.1% |
| Camp4 Therapeutics Corp(CAMP) | COM | 13463J101 | $1.4M | 228,894 | 1.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $1.3M | 893,100 | 1.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $1.3M | 662,666 | 1.0% |
| Omniab Inc(OABI) | COM | 68218J103 | $1.3M | 701,000 | 0.9% |
| Quoin Pharmaceuticals LTD(QNRX) | SPONSORED ADS | 74907L409 | $1.1M | 78,189 | 0.8% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $1.1M | 486,400 | 0.8% |
| Geron Corp(GERN) | COM | 374163103 | $1.1M | 805,800 | 0.8% |
| Abeona Therapeutics Inc(ABEO)Call | COM NEW | 00289Y206 | $1.1M | 200,000 | 0.8% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $1.0M | 87,682 | 0.8% |
| Kezar Life Sciences Inc(KZR) | COM NEW | 49372L209 | $982.4K | 156,179 | 0.7% |
| Edesa Biotech Inc(EDSA) | COM NEW | 27966L306 | $976.3K | 687,500 | 0.7% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $852.1K | 710,071 | 0.6% |
| Radiopharm Theranostics LTD | SPONSORED ADS | 75041J101 | $850.9K | 51,000,000 | 0.6% |
| Semler Scientific Inc(SMLR) | COM | 81684M104 | $764.5K | 50,000 | 0.6% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $727.0K | 469,018 | 0.5% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $715.5K | 627,668 | 0.5% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $634.8K | 204,770 | 0.5% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $626.0K | 463,700 | 0.5% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $595.4K | 45,000 | 0.4% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $489.7K | 86,359 | 0.4% |
| Compugen LTD(CGEN) | ORD | M25722105 | $467.3K | 305,400 | 0.3% |
| Codexis Inc(CDXS) | COM | 192005106 | $417.5K | 256,106 | 0.3% |